Welcome to the LPC Conference 2010

1. Welcome to the LPC Conference 2010

2. Video intro here

3. Welcome to the LPC Conference 2010

4. LPC Conference 2010 Dr. Christopher Hodges Chairman PSNC

10. LPC Conference 2010 Dr. Christopher Hodges Chairman PSNC

11. LPC Conference 2010 Chief Executive’s Report Sue Sharpe

12. Progress beyond dispensing Using the skills of the pharmacist Implementing MURs – 85% of pharmacies Patient approval Public health Progress under the Labour Government

13. A period of uncertainty and transition Service decommissioning Opportunity in chaos NHS to change fundamentally Set the foundations for the new commissioning regime Public health Any Willing Provider – real competition? Getting the evidence together

14. New Government Pharmacy policy White Paper – expansion of pharmacy services Medicines optimisation Funding to reward quality and outcomes Timelines for a new pharmacy contract Financial Constraints Cost of Service Inquiry

15. Pressures affecting Pharmacy Contractors Supply chain Pricing accuracy – PRISM EPS PNAs Specials Responsible Pharmacist & Supervision Confidentiality of data

17. PSNC Budget 2010-11 £3,200,000 Major Expenditure: PRISM PharmaBase New Committee Composition Work programme for 2011

19. Overview • Why PharmaBase is needed • The vision for PharmaBase • PharmaBase functionality at launch • Future developments • The role of LPCs

20. Why is PharmaBase needed? • Problems with Enhanced services • Existing software does not cater for pharmacy’s needs • Potential for an increasing number of commissioners to add complexity to Enhanced service delivery • New NHS mantra: Prove it or lose it!

21. Why is PharmaBase needed? • New national services require support from the start of provision • Don’t want to use paper or wait for modules in PMR systems to be developed • Slow implementation by contractors risks a loss of funding • Need to collate evidence base to support case for ongoing commissioning

22. Why is PharmaBase needed? Problems with Enhanced services: • Variable commissioner paperwork • Variable approaches to invoicing • Slow processing of payment claims by commissioners

23. Why is PharmaBase needed? Problems with Enhanced services (cont.): • Difficulties reconciling payments from PCTs (including accurate assessment of VAT liability) • Difficult to collate management data across a number of pharmacies • Poor data capture by commissioners can lead to a lack of evidence for the value of the service

24. Why is PharmaBase needed? Existing software does not cater for pharmacy’s needs • Focussed on commissioners’ needs • Lack of service and clinical support for pharmacies • Potential for compatibility issues with PMR systems • Some information governance concerns have been raised by contractors • Access to management data for pharmacy use is not always part of the software vendor’s focus or service

25. The PharmaBase Vision To provide a national web based platform to support the efficient commissioning, delivery and invoicing of pharmacy services and to capture the evidence base

26. Our aims • Make service delivery more effective and efficient • Clinical support • Consistent approach across all pharmacies • Drive increased uniformity in commissioning • Increase the efficiency of local payment systems

27. Our aims • Build the national and local evidence base for services • To make it easy to commission and administer pharmacy services! • Allow pharmacy to control its own IT support

28. PharmaBase functionality at launch • EHC service • Pharmacy clinical records • PCT commissioning dataset • Invoicing (including consolidated data across an area) • Supervised Consumption service • Records for PCT claim • Invoicing (including consolidated data across an area) • PSNC Contract Workbook • Linked to CPAF

29. EHC

30. EHC

31. Supervised consumption

33. Contract Workbook

34. Future development of PharmaBase Many possibilities... • Support for new national services • Support for more Enhanced services • Interface with PMRs and other software • Electronic data transfer and sharing with other health professionals

35. The role of LPCs in promoting PharmaBase • Raise contractor awareness • Raise commissioner awareness • Sell the use of the initial three modules • Promote consolidated data approach • Suggest enhancements and new modules to develop

36. Our shared aims • Build the national and local evidence base for services • To make it easy to commission and administer pharmacy services! • Allow pharmacy to control its own IT support

37. www.psnc.org.uk/pharmabase Visit the stand for a demonstration

38. LPC Conference 2010

39. LPC Conference 2010 Your Questions…

40. LPC Conference 2010 Appendix 1 Report on Last Year’s Resolutions

41. LPC Conference 2010 Appendix 2 Adoption of Standing Orders

42. LPC Conference 2010 Appendix 3 Resolutions for 2010

43. LPC Conference 2010 R1 Swindon & Wiltshire LPC This conference calls for a review of the reimbursement of dispensed medicines to ensure that access to retained margin is fair across all contractors. While the overall retained margin is protected, the access to this funding depends not only on the contractor’s purchasing decisions, but on local prescribing policies on branded generics and prescriber use of branded products. This is unfair and must be addressed as a matter of urgency.

44. LPC Conference 2010 R3 Bedfordshire LPC While recognising that the Global Sum for purchase profits may be monitored and maintained, a system which entails the dispensing of branded medicines at a loss and the manipulation of purchase profits at a local level via the prescribing of branded generics is manifestly unfair to individual contractors. 

45. LPC Conference 2010 R4 Cambridgeshire and Peterborough LPC Cambridgeshire and Peterborough LPC calls upon PSNC to insist the DH ensures that the PCTs local prescribing policies do not affect the nationally agreed funding for pharmacy contractors, for example the prescribing of branded generics, thus allowing all contractors to receive fair share remuneration.

46. LPC Conference 2010 R6 Lambeth, Southwark and Lewisham LPC Dispensing at a loss is morally indefensible. This Conference requests PSNC to examine the inconsistencies in prescribing, such as brand switching and prescribing non-discounted items which often results in dispensing at a loss and introduces instability in stock procurement, planning and stockholding and could ultimately be detrimental to patient care.

47. Discussion and Vote Collectively on resolutions R1, R3, R4, and R6

48. LPC Conference 2010 R2 Dorset LPC Dorset LPC believes Community Pharmacy Contractors should share the benefits of their efficient purchasing of medicines. Savings beyond the £500m cap should be re-invested in Community Pharmacy through an Enhanced Services Innovation Fund. This could be used to encourage the transition from a supply, to a service driven remuneration structure, as recommended by the recent Bow Group policy paper.

49. LPC Conference 2010 R5 Wirral LPC This conference calls on PSNC to assure all contractors that current levels of remuneration and fees for Pharmacy Services will continue to be protected at the current levels following devolvement of the global sum and the abolition of PCT’s.

50. LPC Conference 2010 R7 North East London LPC This conference calls on PSNC, Department of Local Government, and the DoH to take immediate steps to formulate plans to develop pharmacy as a centre for local community engagement and health services and put a new ‘contract’ in place as soon as is practicable (but not later than April 2012) that rewards pharmacy contractors for the investment of risk capital and quality of outcomes of pharmacy based services.